Jennifer Biglow, MD
Dermatology · Minneapolis, MNNPI 1629021134
Payments from drug & device makers
Across 23 payments — averaging $25.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$265
- Lilly USA, LLC$54
- Sanofi$32
- Amgen$30
- LEO Pharma Inc.$25
- Sun Pharmaceutical Industries Inc.$23
- plus $156 from 10 others
What the payments were for
- Food & beverage$55595%
- Education$305%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 1 | $265 |
| Lilly USA, LLC | 4 | $54 |
| Sanofi | 2 | $32 |
| Amgen | 2 | $30 |
| LEO Pharma Inc. | 2 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Strata Skin Sciences, Inc. | 2 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $13 |
| Novartis | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Galderma Laboratories, L.p. | 1 | $12 |
How this compares
$585 in reported general payments places this provider in the 65th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 75 | $8,883 |
| Ketoconazole | 169 | $3,411 |
| Fluocinonide | 70 | $2,245 |
| Triamcinolone Acetonide | 144 | $2,145 |
| Clindamycin Phosphate | 59 | $2,025 |
| Minocycline Hcl | 25 | $1,375 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 71 | $1,335 |
| Doxycycline Hyclate | 43 | $1,166 |
| ValacyclovirValacyclovir Hcl | 29 | $1,114 |
| Desonide | 54 | $1,106 |
| Clobetasol Propionate | 37 | $928 |
| Betamethasone Dipropionate | 17 | $512 |
| NystopNystatin | 12 | $382 |
| Mupirocin | 61 | $346 |
| Nystatin | 13 | $218 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Minneapolis
- Maria HordinskyMinneapolis$2.1M
- Margareth Pierre-LouisMinneapolis$456K
- Noah GoldfarbMinneapolis$359K
- Paul BigliardiMinneapolis$237K
- David PearsonMinneapolis$164K
- Kimberly BohjanenMinneapolis$93K
- Brittney SchultzMinneapolis$75K
- Brian ZelicksonMinneapolis$54K
- Sara HylwaMinneapolis$5K
- Timothy AllenMinneapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.